Tt injection dose for adults

Dosage Forms & Strengths Lf (flocculation units) diphtheria/tetanus toxoid injection, suspension (Td) • (2Lf/2Lf)/0.5mL (TDVAX) • (2Lf/5Lf)/0.5mL (Tenivac) Primary Immunization Adults who did not receive primary vaccination series • Give first dose as Tdap, THEN • Give second dose as Td 0.5 mL IM at least 4 weeks after the first dose, THEN • Give third dose as Td 0.5 mL IM 6-12 months later Routine Booster Immunization 0.5 mL (Td or Tdap) every 10 years (patients that have completed primary immunization) Diphtheria Prophylaxis for Case Contacts Indicated for postexposure prophylaxis in persons who have not completed primary vaccination, whose vaccination status is unknown, or who have not been vaccinated with diphtheria toxoid within the previous 5 yr Administer primary series using Td to catch up with vaccinations Tetanus Prophylaxis in Wound Management For active tetanus immunization in wound management, a preparation containing tetanus and diphtheria toxoids (Td) is preferred instead of single-antigen tetanus toxoid to enhance diphtheria protection The need for active immunization with a tetanus toxoid-containing preparation, with or without passive immunization with tetanus immune globulin (TIG) depends on both the condition of the wound and the patient’s vaccination history Clean minor wounds • Unknown or 10 years since last dose): Administer Td All other wounds • Unknown or 5 yr since last dose): Administer Td; if patient has history of Arhus-type reaction, administe...

In deciding to receive this vaccine, the risks of receiving the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For tetanus toxoid, the following should be considered: Allergies Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Pediatric Use is not recommended for infants up to 6 weeks of age. For infants and children 6 weeks of age and older, tetanus toxoid is not expected to cause different side effects or problems than it does in adults. Geriatric This vaccine is not expected to cause different side effects or problems in older people than it does in younger adults. However, the vaccine may be slightly less effective in older persons than in younger adults. Breastfeeding There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may b...